Oseltamivir-resistant influenza A(H1N1) 2009 virus in Greece during the post-pandemic 2010-2011 season

被引:5
作者
Kourti, Afroditi [1 ]
Spanakos, Gregory [1 ,2 ]
Politi, Leda [1 ]
Stavropoulou, Anastasia [1 ]
Spanakis, Nicholas [1 ]
Tsakris, Athanassios [1 ]
机构
[1] Univ Athens, Sch Med, Dept Microbiol, Virol Unit, GR-11527 Athens, Greece
[2] Hellen Ctr Dis Control & Prevent, Athens 15123, Greece
关键词
Influenza H1N1; Oseltamivir; Resistance; Post-pandemic influenza season; H1N1;
D O I
10.1016/j.ijantimicag.2012.03.021
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Information on the drug susceptibility of influenza epidemic strains is important for antiviral resistance monitoring. In Greece, the 2009-2010 pandemic waves were very mild and seroprevalence rates remained low after this influenza season, resulting in exclusive detection of the pandemic strain during the 2010-2011 influenza season. In the present study during the post-pandemic 2010-2011 season, 50 consecutive influenza A(H1N1) 2009 virus-positive samples from patients hospitalised in Greek hospitals were analysed for resistance to the neuraminidase inhibitor oseltamivir. All patients were hospitalised with severe influenza complications and had previously received oseltamivir. Influenza A(H1N1) 2009 virus detection and testing for oseltamivir resistance were performed with real-time PCR amplification assays. The H275Y substitution associated with resistance to oseltamivir was identified in two immunocompetent patients who received oseltamivir treatment for 3 days and 5 days, respectively. In both cases, patients were discharged in good condition despite development of resistance to antiviral treatment. (C) 2012 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 15 条
[11]   Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece [J].
Maltezou, Helena C. ;
Katerelos, Panagiotis ;
Mavrouli, Maria ;
Lourida, Athanasia ;
Routsias, John G. ;
Spanakis, Nicholas ;
Maragos, Antonios ;
Tedoma, Anastasia ;
Bassiakos, Yiannis ;
Koratzanis, Georgios ;
Mantagos, Stephanos ;
Metallidis, Simeon ;
Katragkou, Aspasia ;
Nikolaidis, Pavlos ;
Roilides, Emmanuel ;
Theodoridou, Maria ;
Tsakris, Athanassios .
VACCINE, 2011, 29 (38) :6664-6669
[12]  
Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]
[13]  
Neuraminidase Inhibitor Susceptibility Network, 2007, WKLY EPIDEMIOL REC, V82, P141
[14]  
WHO, 2011, UPD OS RES INFL A H1
[15]  
World Health Organization, SUMM 1 PAND INFL SEA